“jmp-securities” Archives

in
Entry Author Date Location
ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson’s Promise 02/19/20 Boston
Vertex Selects Drug Combo, a Potential Therapy for 90% of CF Patients 05/30/19 Boston
After NASH Drug’s 2nd Failure, Gilead Pins Hopes on Combo Therapies 04/25/19 San Francisco
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Sarepta Touts New Data and a “Signal” With Duchenne Gene Therapy 10/03/18 Boston
FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study 05/30/18 Boston
Blueprint Medicines Bags $147M in Upsized IPO 04/29/15 Boston
Alexion Deal in Hand, Blueprint Readies IPO Pitch 03/23/15 Boston
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
Proteon, Moving on From Ill-Fated Novartis Deal, Files IPO Pitch 09/16/14 Boston
Zafgen Hauls In $96M in Upsized IPO 06/18/14 Boston
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push 04/20/14 Boston
Cerulean Limps into Nasdaq Debut With $7 Per Share IPO 04/10/14 Boston
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Karyopharm Prices Upsized IPO at $16 Per Share, Begins Trading Today 11/06/13 Boston
Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug 10/07/13 Boston
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday 09/19/13 Boston
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
AcelRx Gets $40M in IPO 02/11/11 San Francisco
Optimer Nabs $68M in Stock Sale 02/11/11 San Diego
Oncothyreon Raises $14.9M 09/24/10 Seattle
Trius Puts the Brakes on IPO Plan, While It Adjusts to New FDA Clinical Guidelines 03/05/10 San Diego
Optimer Rides Investment See-Saw With Promising Drug for “C.diff” Infections 06/05/09 San Diego
Page 1 of 2 next page »